The global herpes labialis drugs market is anticipated to grow at a CAGR of 4.0% during the forecast period. Herpes labialis is a viral infection caused by the herpes simplex virus 1 (HSV-1). Herpes simplex virus type 1 (HSV-1) is a cause of recurrent vesiculoulcerative lesions of the oral or genital mucosa. It can also cause infection in the eye, skin, central nervous system, and/or visceral organs. Antiviral agents available for HSV infection include acyclovir, valacyclovir, and famciclovir. The growing prevalence of herpes labialis among children and adults across the globe is the factor that is driving the market growth. According to WHO, an estimated 3.7 billion people under age 50 (67%) have HSV-1 infection, and an estimated 491 million people aged 15–49 (13%) have HSV-2 infection globally. With increasing prevalence, it is expected that the demand for herpes labialis drugs will increase significantly.
Get Free Sample link @ https://www.omrglobal.com/request-sample/herpes-labialis-drugs-market
Besides, the rising government programs for sexually transmitted disease awareness are expected to propel market growth. As HSV-2 is mainly transmitted during sex through contact with genital or anal surfaces, skin, sores, or fluids of someone infected with the virus. However, the high cost of treatment and strict government rules and regulations related to drug approval is expected to impact the growth of the market.
A full report of Global Herpes Labialis Drugs Market available @ https://www.omrglobal.com/industry-reports/herpes-labialis-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Herpes Labialis Drugs Market by Type
- Acyclovir
- Valacyclovir
- Penciclovir
- Famciclovir
- Docosanol
Global Herpes Labialis Drugs Market by Route of Administration
- Oral
- Topical
- Parenteral
Global Herpes Labialis Drugs Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Abbott Laboratories
- Alembic Pharmaceuticals, Ltd.
- Apotex, Inc.
- Aurobindo Pharma Ltd.
- Bausch Health Companies, Inc.
- Blistex, Inc.
- Cipla, Ltd.
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals PLC
- Jubilant Cadista
- LGM Pharma
- Mylan N.V.
- Novartis AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries, Ltd.
- Taj Pharmaceuticals, Ltd.
- Teva Pharmaceutical Industries, Ltd.
- Torrent Pharmaceuticals, Ltd.
- Valeant Pharmaceuticals International Inc. (Bausch Health)
- Zydus Cadila, Ltd.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global herpes labialis drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/herpes-labialis-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
